MedWatch

A part of Watch Media

Philips has grown stronger from the pandemic: This has been an organizational stress test

Few other firms have been on the front lines of the Covid-19 pandemic to the same extent that healthtech firm Philips has, with the crisis causing marked organizational changes in the Nordic business, while infection rates were at a high.

Philips Nordics Vice President Nille Klæbel. | Photo: Philips / PR
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

At Philips Nordics, staff members held their breaths, went Scandinavia went into lockdown in spring.

What would happen to the product sales that depended on open clinics and stores? And how would the firm accommodate the massively increased demand for products that can supply oxygen and monitor intensive-care patients?

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

  1. Genmab to submit cancer candidate epcoritamab to the FDA before year-end
  2. Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
  3. Novo Holdings portfolio company sold to US buyer
  4. Life science firms are planning USD 6.3bn construction spree in Denmark
  5. Lundbeck Foundation brings in experienced player to implement investment strategy
  6. Fujifilm invests USD 1.5bn in Danish factory
  7. Sanofi reduces US insulin prices for the uninsured
  8. Janssen awarded breakthrough therapy designation for Genmab bone marrow cancer drug
  9. Leo Pharma eczema treatment recommended in two UK countries
  10. Overview: Pharma giants and Bavarian Nordic fight over billion-dollar vaccine market
  11. Fruergaard leveraging experience from Danish partnerships in key roles in Brussels
  12. Eargo raises USD 100m from investment firm
  13. US authorities expand monkeypox vaccine plan
  14. Stallergenes slapped with injunction
  15. EMA starts assessment of Bavarian Nordic's monkeypox vaccine

See all

Job

See all jobs

See all jobs